학술논문
A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group
Document Type
Discussion
Source
In Lancet Oncology April 2014 15(4):e184-e193
Subject
Language
ISSN
1470-2045